Brugada Syndrome 4
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetics of Brugada syndrome.
|
27761167 |
2016 |
Brugada Syndrome 4
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.
|
17224476 |
2007 |
Brugada Syndrome 4
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Brugada Syndrome 4
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Brugada Syndrome 4
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay.
|
22090166 |
2012 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.
|
22840528 |
2012 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
These results are the first to identify CACNA2D1 as a novel BrS susceptibility gene and CACNA1C, CACNB2, and CACNA2D1 as possible novel ERS susceptibility genes.
|
20817017 |
2010 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome.
|
19358333 |
2009 |
Brugada Syndrome (disorder)
|
0.510 |
GeneticVariation
|
disease |
LHGDN |
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.
|
17224476 |
2007 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.
|
17224476 |
2007 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Cloning of the beta(2a) subunit of the voltage-dependent calcium channel from human heart: cooperative effect of alpha(2)/delta and beta(2a) on the membrane expression of the alpha(1C) subunit.
|
10623591 |
2000 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study.
|
31268507 |
2019 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
|
29483656 |
2018 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
|
28540026 |
2017 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia.
|
28991256 |
2017 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
RNA-sequencing analyses of cortical and striatal micropunches from Brd1<sup>+/-</sup> and wild-type mice revealed differential expression of genes enriched for schizophrenia risk, including several schizophrenia genome-wide association study risk genes (e.g., calcium channel subunits [Cacna1c and Cacnb2], cholinergic muscarinic receptor 4 [Chrm4)], dopamine receptor D<sub>2</sub> [Drd2], and transcription factor 4 [Tcf4]).
|
27837920 |
2017 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of schizophrenia in Ashkenazi Jews.
|
26198764 |
2015 |
Schizophrenia
|
0.430 |
Biomarker
|
disease |
BEFREE |
CTCF and CACNB2, evidence for association with schizophrenia was available (at the gene-level) in both the discovery study and published data from the Psychiatric Genomics Consortium schizophrenia study.
|
24901509 |
2014 |
Schizophrenia
|
0.430 |
Biomarker
|
disease |
PSYGENET |
CTCF and CACNB2, evidence for association with schizophrenia was available (at the gene-level) in both the discovery study and published data from the Psychiatric Genomics Consortium schizophrenia study.
|
24901509 |
2014 |
Schizophrenia
|
0.430 |
Biomarker
|
disease |
BEFREE |
This gene set included known schizophrenia risk genes, such as neural cell adhesion molecule (NRCAM) and calcium channel, voltage-dependent, beta 2 subunit (CACNB2), as well as genes with well-defined roles in neurodevelopmental and plasticity processes that are dysfunctional in schizophrenia and have mechanistic links to prefrontal-hippocampal functional interactions.
|
24979789 |
2014 |
Schizophrenia
|
0.430 |
GeneticVariation
|
disease |
GWASCAT |
Biological insights from 108 schizophrenia-associated genetic loci.
|
25056061 |
2014 |